Corrigendum: Therapy by physician-pharmacist combination and economic returns for cancer pain management in China: a cost-effectiveness analysis

Xikui Lu; Lu Zhang; Hangxing Huang; Xiangping Wu; Zhenting Wang; Ling Huang; Jingyang Li; Huimin Yu; Hongyan Zhang; Jian Xiao

doi:10.3389/fphar.2023.1327256

Corrigendum: Therapy by physician-pharmacist combination and economic returns for cancer pain management in China: a cost-effectiveness analysis

Front Pharmacol. 2023 Nov 17:14:1327256. doi: 10.3389/fphar.2023.1327256. eCollection 2023.

Authors

Xikui Lu^{1

2

3}, Lu Zhang^{1

2}, Hangxing Huang^{1

2

3}, Xiangping Wu^{1

2

3}, Zhenting Wang^{1

2

3}, Ling Huang^{1

2}, Jingyang Li^{1

2}, Huimin Yu^{1

2}, Hongyan Zhang^{1

4}, Jian Xiao^{1

2}

Affiliations

¹ Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, China.
² National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
³ College of Pharmacy, Dali University, Dali, China.
⁴ Department of Pharmacy, Fuwai Central China Cardiovascular Hospital, Zhengzhou, China.

Abstract

[This corrects the article DOI: 10.3389/fphar.2023.1073939.].

Keywords: cancer pain; cost-effectiveness analysis; decision trees; economics; physician-pharmacist.

Publication types

Published Erratum